These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
532 related articles for article (PubMed ID: 28990243)
21. Tissue and exosomal miRNA editing in Non-Small Cell Lung Cancer. Nigita G; Distefano R; Veneziano D; Romano G; Rahman M; Wang K; Pass H; Croce CM; Acunzo M; Nana-Sinkam P Sci Rep; 2018 Jul; 8(1):10222. PubMed ID: 29976955 [TBL] [Abstract][Full Text] [Related]
22. Assessment of Circulating miRNA-17 and miRNA-222 Expression Profiles as Non-Invasive Biomarkers in Egyptian Patients with Non-Small-Cell Lung Cancer. Hetta HF; Zahran AM; El-Mahdy RI; Nabil EE; Esmaeel HM; Elkady OA; Elkady A; Mohareb DA; Mahmoud Mostafa M; John J Asian Pac J Cancer Prev; 2019 Jun; 20(6):1927-1933. PubMed ID: 31244320 [TBL] [Abstract][Full Text] [Related]
23. MicroRNAs as early diagnostic biomarkers for non‑small cell lung cancer (Review). Liang X; Wu Q; Wang Y; Li S Oncol Rep; 2023 Jan; 49(1):. PubMed ID: 36382661 [TBL] [Abstract][Full Text] [Related]
24. Clinical implication of microrna for lung cancer. Wang Y; Zhang X; Liu L; Li H; Yu J; Wang C; Ren X Cancer Biother Radiopharm; 2013 May; 28(4):261-7. PubMed ID: 23496233 [TBL] [Abstract][Full Text] [Related]
25. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer. Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428 [TBL] [Abstract][Full Text] [Related]
26. Exploration of Serum Exosomal LncRNA TBILA and AGAP2-AS1 as Promising Biomarkers for Diagnosis of Non-Small Cell Lung Cancer. Tao Y; Tang Y; Yang Z; Wu F; Wang L; Yang L; Lei L; Jing Y; Jiang X; Jin H; Bai Y; Zhang L Int J Biol Sci; 2020; 16(3):471-482. PubMed ID: 32015683 [TBL] [Abstract][Full Text] [Related]
27. Significance of miR-15a-5p and CNKSR3 as Novel Prognostic Biomarkers in Non-Small Cell Lung Cancer. Ergun S; Güney S; Temiz E; Petrovic N; Gunes S Anticancer Agents Med Chem; 2018; 18(12):1695-1701. PubMed ID: 30019650 [TBL] [Abstract][Full Text] [Related]
28. MicroRNA-486 as a Biomarker for Early Diagnosis and Recurrence of Non-Small Cell Lung Cancer. Li W; Wang Y; Zhang Q; Tang L; Liu X; Dai Y; Xiao L; Huang S; Chen L; Guo Z; Lu J; Yuan K PLoS One; 2015; 10(8):e0134220. PubMed ID: 26237047 [TBL] [Abstract][Full Text] [Related]
29. Tumor-derived exosomal miR-619-5p promotes tumor angiogenesis and metastasis through the inhibition of RCAN1.4. Kim DH; Park S; Kim H; Choi YJ; Kim SY; Sung KJ; Sung YH; Choi CM; Yun M; Yi YS; Lee CW; Kim SY; Lee JC; Rho JK Cancer Lett; 2020 Apr; 475():2-13. PubMed ID: 32004570 [TBL] [Abstract][Full Text] [Related]
30. Relationship between diagnostic accuracy of microRNAs for NSCLC and number of combined microRNAs: an overview with meta-analysis. Li M; Gao Y; Shi J; Zhang Y; Zhang M; Tian J Expert Rev Mol Diagn; 2021 Sep; 21(9):983-993. PubMed ID: 34192984 [No Abstract] [Full Text] [Related]
31. microRNA and Lung Cancer. Del Vescovo V; Denti MA Adv Exp Med Biol; 2015; 889():153-77. PubMed ID: 26659001 [TBL] [Abstract][Full Text] [Related]
32. Clinical Relevance of Circulating, Cell-Free and Exosomal microRNAs in Plasma and Serum of Breast Cancer Patients. Schwarzenbach H Oncol Res Treat; 2017; 40(7-8):423-429. PubMed ID: 28683441 [TBL] [Abstract][Full Text] [Related]
33. Hypoxic BMSC-derived exosomal miRNAs promote metastasis of lung cancer cells via STAT3-induced EMT. Zhang X; Sai B; Wang F; Wang L; Wang Y; Zheng L; Li G; Tang J; Xiang J Mol Cancer; 2019 Mar; 18(1):40. PubMed ID: 30866952 [TBL] [Abstract][Full Text] [Related]
34. Exosomal miRNA Analysis in Non-small Cell Lung Cancer (NSCLC) Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool. Giallombardo M; Chacártegui Borrás J; Castiglia M; Van Der Steen N; Mertens I; Pauwels P; Peeters M; Rolfo C J Vis Exp; 2016 May; (111):. PubMed ID: 27285610 [TBL] [Abstract][Full Text] [Related]
35. Cell-free microRNAs as diagnostic, prognostic, and predictive biomarkers for lung cancer. Zandberga E; Kozirovskis V; Ābols A; Andrējeva D; Purkalne G; Linē A Genes Chromosomes Cancer; 2013 Apr; 52(4):356-69. PubMed ID: 23404859 [TBL] [Abstract][Full Text] [Related]
36. Increased Plasma miRNA-30a as a Biomarker for Non-Small Cell Lung Cancer. Sun L; Chen Y; Su Q; Tang X; Liang Y; Che G; Luo F Med Sci Monit; 2016 Feb; 22():647-55. PubMed ID: 26918265 [TBL] [Abstract][Full Text] [Related]
37. Aberrant miR-181b-5p and miR-486-5p expression in serum and tissue of non-small cell lung cancer. Tian F; Shen Y; Chen Z; Li R; Lu J; Ge Q Gene; 2016 Oct; 591(2):338-43. PubMed ID: 27291819 [TBL] [Abstract][Full Text] [Related]
38. Utilizing MiSeq Sequencing to Detect Circulating microRNAs in Plasma for Improved Lung Cancer Diagnosis. Geng X; Tsou JH; Stass SA; Jiang F Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373422 [TBL] [Abstract][Full Text] [Related]
39. miRNAs as Biomarkers and Therapeutic Targets in Non-Small Cell Lung Cancer: Current Perspectives. Florczuk M; Szpechcinski A; Chorostowska-Wynimko J Target Oncol; 2017 Apr; 12(2):179-200. PubMed ID: 28243959 [TBL] [Abstract][Full Text] [Related]
40. Five microRNAs in plasma as novel biomarkers for screening of early-stage non-small cell lung cancer. Geng Q; Fan T; Zhang B; Wang W; Xu Y; Hu H Respir Res; 2014 Nov; 15(1):149. PubMed ID: 25421010 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]